XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (18,728,498) $ (17,839,057)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization of debt discount 401,775 333,939
Amortization of capitalized software 8,021,141 5,424,810
Amortization of intangibles 982,405 971,464
Accretion of consideration payable 13,644 167,221
Depreciation of fixed assets 487,976 203,952
Write-down of inventory 675,669 537,685
Loss on debt extinguishment 325,198
Noncash operating lease expense 776,080 766,280
Stock issued for legal settlement 532,000
Stock compensation expense 12,234,797 12,489,343
Changes in Assets and Liabilities    
Accounts receivable (2,940,563) (2,442,500)
Product deposit 445,087 (358,585)
Inventory (713,095) 405,746
Other current assets (1,737,721) (247,488)
Operating lease liabilities (485,079) (808,368)
Deferred revenue 5,652,319 3,281,092
Accounts payable 4,924,629 978,062
Accrued expenses 7,502,624 4,678,757
Other operating activity (579,319)
Net cash provided by operating activities 17,513,190 8,820,232
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for capitalized software costs (10,041,663) (8,380,602)
Purchase of equipment (1,490,857) (203,814)
Purchase of intangible assets (3,798) (148,868)
Net cash used in investing activities (11,536,318) (8,733,284)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net 19,466,887
Cash proceeds from common stock issued to Medifast 10,000,000
Proceeds from notes payable 2,347,691
Sale of common stock under ATM, net 6,202,659
Repayment of notes payable, net of prepayment penalty (327,597) (5,142,542)
Cash proceeds from exercise of options 120,312 94,500
Preferred stock dividends (3,106,250) (3,106,250)
Contingent consideration payments for ResumeBuild acquisition (31,250) (312,500)
Net payments for membership interest in WorkSimpli (305,625)
Distributions to non-controlling interest (773,888) (144,000)
Net cash (used in) provided by financing activities (4,118,673) 29,100,820
Net increase in cash 1,858,199 29,187,768
Cash at beginning of year 33,146,725 3,958,957
Cash at end of year 35,004,924 33,146,725
Cash paid for interest    
Cash paid during the period for interest 2,528,042 2,148,454
Non-cash investing and financing activities    
Cashless exercise of options 5,127 744
Cashless exercise of warrants 16,305 793
Stock issued for noncontingent consideration payments 642,000 2,568,000
Stock issued for debt conversion 1,000,000
Series B Preferred Stock conversion 5,072,814
Warrants issued for debt instruments 873,100
Right of use assets 6,581,779 155,168
Operating lease liabilities $ 6,581,779 $ 155,168